Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany

European Journal of Medical Research

Volumn 15, Issue 3, 2010, Pages 124-130

  Gross, Manfred ^a   Beckenbauer, U ^b   Burkowitz, J ^c   Walther, H ^b   Brueggenjuergen, B ^c  

^a Internistische Klinik Dr Muller   (Germany)

^b H M O Health Management Online AG   (Germany)

^c Alpha Care GmbH   (Germany)

Author keywords

Gastro oesophageal reflux; Medical economics; Proton pump inhibitors; Sick leave

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ABSENTEEISM; ADULT; ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSPEPSIA; EMOTIONAL STRESS; FEMALE; GASTROESOPHAGEAL REFLUX; GERMANY; HEALTH ECONOMICS; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PATIENT CARE; PHYSICAL CAPACITY; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; SOCIAL INTERACTION; SYMPTOM; OBSERVATIONAL STUDY; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY;

EID: 77950973338     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-15-3-124     Document Type: Article

References (27)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 May; 54(5): 710-7.
2. Willich SN, Nocon M, Kulig M, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther 2006 Feb 1;23(3):371-376 (Pubitemid 43382017)
3. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; Oct 15;18(8):767-776
4. Nocon M, Keil T, Willich SN. Prevalence and sociodemographics of reflux symptoms in Germany - results from a national survey. Aliment Pharmacol Ther 2006 Jun 1;23(11): 1601-1605 (Pubitemid 43727468)
5. Hungin AP, Raghunath AS, Wiklund I. Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease. Fam Pract. 2005 Dec; 22(6):591-603.
6. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004; 22(2): 108-114 (Pubitemid 39274305)
7. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastrooesophageal reflux symptoms and health-related quality of life in the adult general population - the Kalixanda study. Aliment Pharmacol Ther 2006 Jun 15;23(12):1725-33. (Pubitemid 43846416)
8. Wahlqvist P, Reilly MC, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther 2006 Jul 15; 24(2): 259-272
9. Wahlqvist P, Brook RA, Campbell SM, Wallander MA, Alexander AM, Smeeding JE, Kleinman NL. Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease. J Occup Environ Med 2008 Jan;50(1):25-31.
10. Leodolter A, Nocon M, Kulig M, Willich SN, Malfertheiner P, Labenz J. Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort study. World J Gastroenterol 2005 Dec 7;11(45):7148-7151 (Pubitemid 43154010)
11. Liker H, Jones R, Ducrotte P. The effect of sleep disturbance due to gastroesophageal reflux diesease on work and leisure productivity: results from a multinational survey. Gastroenterology 2005; 128: A386
12. Meining A, Driesnack U, Classen M, Rösch T. Management of gastroesophageal reflux disease in primary care: results of a survey in 2 areas in Germany. Z Gastroenterol 2002 Jan; 40(1): 15-20. (Pubitemid 34121684)
13. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Paré P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998; 583: 41-49 (Pubitemid 29054907)
14. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I. Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Dig Dis Sci 2001 Mar; 46(3): 571-580 (Pubitemid 32299813)
15. Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdörffer E, Miehlke S, Carlsson J, Wiklund IK. Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes 2003 Oct 28; 1: 62.
16. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001 Jan; 96(1): 52-57 (Pubitemid 32104807)
17. Nocon M, Kulig M, Leodolter A, Malfertheiner P, Willich SN. Validation of the Reflux Disease Questionnaire for a German population. Eur J Gastroenterol Hepatol 2005 Feb; 17(2): 229-233 (Pubitemid 40349538)
18. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993 Nov; 4(5): 353-65.
19. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastroesophageal reflux disease (WPAI-GERD) - results from a cross-sectional study. Value Health 2002 Mar-Apr; 5(2):106-113 (Pubitemid 34274868)
20. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol 2001 Aug; 96(8 Suppl): S57-61. (Pubitemid 32758211)
21. Calleja JL, Bixquert M, Maldonado J. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig Dis Sci 2007 Oct; 52(10): 2858-2865
22. Rey E, Elola-Olaso C, Rodríguez Artalejo F, Díaz-Rubio M. Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain. Rev Esp Enferm Dig 2006 Jul; 98(7): 518-526 (Pubitemid 350104420)
23. Stewart WF, Ricci JA, Leotta C. Health-related lost productive time (LPT): recall interval and bias in LPT estimates. J Occup Environ Med 2004 Jun; 46(6 Suppl): S12-22. (Pubitemid 38747690)
24. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003 May 15; 17(10): 1309-1317 (Pubitemid 36693732)
25. Jones R, Annstrog D, Mnalfertheiner P, Ducrotté P. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin 2006 April; 22(4): 657-62.
26. Kirby CN, Piterman L, Nelson MR, Dent J. Gastro-oesophageal reflux disease-impact of guidelines on GP management. Aust Fam Physician 2008 Jan-Feb; 37(1-2): 73-7.
27. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996 Nov;10(5):460-6.